TCM
HURA

TT Capital Management’s TuHURA Biosciences HURA Stock Holding History

TT Capital Management’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.9K Hold
10,000
– – 0.01% 73
2025
Q4 		$7.57K Hold
10,000
– – 0.01% 73
2025
Q3 		$24.8K Hold
10,000
– – 0.02% 69
2025
Q2 		$22.3K Hold
10,000
– – 0.02% 68
2025
Q1 		$32.3K Hold
10,000
– – 0.03% 68
2024
Q4 		$47.3K Buy
+10,000
New +$53.2K 0.04% 73

Other funds holding HURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

TT Capital Management's HURA Position: Q1 2026 in Review

TT Capital Management held its TuHURA Biosciences (HURA) position steady in Q1 2026 at 10,000 shares worth $17.9K. The position accounts for 0.01% of the portfolio, ranked #73.

TT Capital Management first reported a position in HURA in Q4 2024 and has held it in 6 quarters since. The position peaked at $47.3K in Q4 2024. 89 funds tracked by Wall St. Rank hold HURA as of Q1 2026.

  • TT Capital Management held 10,000 shares of TuHURA Biosciences worth $17.9K as of Q1 2026.
  • TT Capital Management left its TuHURA Biosciences share count unchanged in Q1 2026.
  • TuHURA Biosciences made up 0.01% of TT Capital Management's portfolio in Q1 2026, its #73 holding.
  • TT Capital Management first reported a position in TuHURA Biosciences in Q4 2024 and has held it in 6 quarters since.
  • TT Capital Management's TuHURA Biosciences position peaked at $47.3K in Q4 2024.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2026.

Based on TT Capital Management's 13F filing for Q1 2026, filed 12 May 2026.